Citations 27

Severe Parsonage-Turner Syndrome and Surgically Managed Traumatic Brachial Plexopathy

Neurology | August 28, 2026 | Volume: 107 | Issue: 6 | Pages: No page available

10.1212/wnl.0000000000218501 | PMID 42664489

Compound Muscle Action Potential and Myosin-Loss Pathology in Patients With Critical Illness Myopathy

Neurology | June 13, 2024 | Volume: 103 | Issue: 1 | Pages: No page available

10.1212/wnl.0000000000209496 | PMID 38870464

Schwann Cell Remyelination in Neuromyelitis Optica: Implications for CNS Repair (S32.007)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206321

Compound Muscle Action Potential (CMAP) Duration and Myosin Loss in Patients with Critical Illness Myopathy: Correlation and Prognostication (P1-11.005)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000205833

Results from a Phase 2 Clinical Trial of Repeated Intrathecal Autologous Adipose-derived MSCs in ALS (S5.004)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000204894

A Novel Genotype and Pathological Phenotype in a Patient with Myosin Heavy Chain 2A Myopathy (P5.440)

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.p5.440

Necrotizing Autoimmune Myopathy Associated with Tubular Aggregates (P3.4-006)

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p3.4-006

Carpal and Cubital Tunnel Surgical Release in HNPP and CMT1A: Success Predictors and Outcomes (P9-13.004)

Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available

10.1212/wnl.98.18_supplement.1378

Open-Spaced Ridged Hydrogel Scaffolds Containing TiO2-Self-Assembled Monolayer of Phosphonates Promote Regeneration and Recovery Following Spinal Cord Injury

International Journal of Molecular Sciences | June 16, 2023 | Volume: 24 | Issue: 12 | Pages: 10250

10.3390/ijms241210250 | PMID 37373396

The spinal cord has a poor ability to regenerate after an injury, which may be due to cell loss, cyst formation, inflammation, and scarring. A promising approach to treating a spinal cord injury (SCI) is the use of biomaterials. We have developed a novel hydrogel scaffold fabricated from oligo(poly(ethylene glycol) fumarate) (OPF) as a 0.08 mm thick sheet containing polymer ridges and a cell-attractive surface on the other side. When the cells are cultured on OPF via chemical patterning, the cells attach, align, and deposit ECM along the direction of the pattern. Animals implanted with the rolled scaffold sheets had greater hindlimb recovery compared to that of the multichannel scaffold control, which is likely due to the greater number of axons growing across it. The immune cell number (microglia or hemopoietic cells: 50–120 cells/mm2 in all conditions), scarring (5–10% in all conditions), and ECM deposits (Laminin or Fibronectin: approximately 10–20% in all conditions) were equal in all conditions. Overall, the results suggest that the scaffold sheets promote axon outgrowth that can be guided across the scaffold, thereby promoting hindlimb recovery. This study provides a hydrogel scaffold construct that can be used in vitro for cell characterization or in vivo for future neuroprosthetics, devices, or cell and ECM delivery.
Pre-existing Lambert-Eaton Myasthenic Syndrome and Scleroderma in a Patient with Neuroendocrine Tumor undergoing Immune Checkpoint Inhibitor Cancer Immunotherapy (P4-5.029)

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000203728